This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klemens, S. P. Articles by Cynamon, M. H. Search for Related Content PubMed PubMed Citation Articles by Klemens, S. P. Articles by Cynamon, M. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 01 1996, 14-16, Vol 40, No. 1
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Activity of pyrazinamide in a murine model against Mycobacterium tuberculosis isolates with various levels of in vitro susceptibility

SP Klemens, CA Sharpe and MH Cynamon
State University of New York Health Science Center, Syracuse 13210, USA.

The activity of pyrazinamide (PZA) against eight isolates of Mycobacterium tuberculosis in a murine infection model was evaluated. M. tuberculosis isolates with various degrees of in vitro susceptibility to PZA (MIC range, 32 to > 2,048 micrograms/ml) were used. Four-week-old female mice were infected intravenously with approximately 10(7) viable M. tuberculosis organisms. PZA at 150 mg/kg of body weight was started 1 day postinfection and given 5 days/week for 4 weeks. Infected but untreated mice were compared with PZA-treated mice. Mice were sacrificed at the completion of the treatment period, and viable cell counts were determined from homogenates of spleens and right lungs. PZA had activity in the murine test system against M. tuberculosis isolates for which the MICs were < or = 256 micrograms/ml. However, there was an inconsistent correlation between the absolute MICs and the reductions in organ viable cell counts. Studies with drug- resistant M. tuberculosis isolates with an isogenic background would improve evaluation of drug efficacy in the murine test system. Further evaluation of antimycobacterial agents against monodrug-resistant isolates will provide data that will be useful for development of algorithms for treatment of infection with drug-resistant organisms.

This article has been cited by other articles:

• Mendez, S., Traslavina, R., Hinchman, M., Huang, L., Green, P., Cynamon, M. H., Welch, J. T. (2009). The Antituberculosis Drug Pyrazinamide Affects the Course of Cutaneous Leishmaniasis In Vivo and Increases Activation of Macrophages and Dendritic Cells. Antimicrob. Agents Chemother. 53: 5114-5121 [Abstract] [Full Text]  
• Turner, D. J., Hoyle, S. L., Snewin, V. A., Gares, M.-P., Brown, I. N., Young, D. B. (2002). An ex vivo culture model for screening drug activity against in vivo phenotypes of Mycobacterium tuberculosis. Microbiology 148: 2929-2936 [Abstract] [Full Text]